40 reports

NOVEL STRATEGIES IN THE ORAL DELIVERY OF ANTIDIABETIC PEPTIDE DRUGS - INSULIN, GLP-## AND ITS ANALOGS.

  • Drug Development
  • North America
  • Ironwood Pharmaceuticals, Inc.
  • Novo Nordisk Group
  • Oramed Pharmaceuticals Inc.
  • Revenue in USD million, 2016-2018

Net revenue in Oral Drug Delivery segment decreased by USD ##. ## million, or ##%, compared to 2017.

  • Drug Development
  • North America
  • Baxter International Inc.
  • Hangzhou Tigermed Consulting Co., Ltd
  • PAREXEL International Corporation
  • STORAGE
  • PATENTS ANALYSIS: DISTRIBUTION BY TYPE

TARGETED DRUG / THERAPY DELIVERY ##. ##. ##.

  • Drug Development
  • North America
  • Erytech Pharma SA
  • Neurotech Pharmaceuticals, Inc.
  • ViaCyte, Inc.

IN ADDITION, WE OBSERVED THAT NEARLY ##% OF THE PLATFORMS WERE DESIGNED TO DEVELOP DRUG DELIVERY MODALITIES.

  • Drug Development
  • North America
  • Company Sales
  • Demand
  • Market Size

" [We need] ways of getting people to take all of the drugs... and so, sustained [drug] delivery would be a huge step forward. "

  • Drug Development
  • North America
  • Aerie Pharmaceuticals, Inc.
  • Allergan plc
  • Santen Pharmaceutical Co., Ltd.

THERAPEUTIC DRUG MONITORING REAGENTS USED FOR THE MEASUREMENT OF DRUGS SPECIFIC FOR CENTRAL NERVOUS SYSTEM ARE COVERED UNDER CENTRAL NERVOUS SYSTEMS TDM.

  • Drug Development
  • North America
  • Forecast
  • Beckman Coulter, Inc.
  • bioMerieux S.A.

TECHNOLOGICAL ADVANCEMENTS IN AUTOSAMPLERS HAVE ENABLED THE DELIVERY OF ACCURATE SAMPLES TO THE ANALYZER.

  • Drug Development
  • North America
  • Market Size
  • Agilent Technologies, Inc.
  • Shimadzu Corporation

IT OFFERS A FULL SPECTRUM OF DISCOVERY SERVICES, WHICH INCLUDE IDENTIFICATION OF A NOVEL DRUGGABLE TARGET, HIGH-THROUGHPUT SCREENING AND MEDICAL CHEMISTRY, AND DELIVERY OF A NON-CLINICAL DRUG FOR SAFETY ASSESSMENT.

  • Drug Development
  • North America
  • Company
  • BioNTech AG.
  • Evotec AG

THE TECHNOLOGY ENABLES THE ORAL DELIVERY OF BIOLOGICS AND LIVE BIOTHERAPEUTIC DRUGS, AS WELL AS SYSTEMIC DELIVERY OF SENSITIVE DRUGS.

  • Clinical Trial
  • Drug Development
  • North America
  • Market Size
  • MicroBiome Therapeutics LLC

THE FEASIBLE DELIVERY OF THIS THERAPY THROUGH INSTITUTIONS AND CLINICS ACROSS THE GLOBE IS AS ONE OF THE PROBLEMS.

  • Drug Development
  • North America
  • Company
  • Market Size
  • Juno Therapeutics Inc.

COLLABORATIONS ##. ##. ##M MICRONEEDLE DRUG DELIVERY TECHNOLOGY (##M DRUG DELIVERY SYSTEMS) ##. ##. ##.

  • Clinical Trial
  • Drug Development
  • North America
  • LipimetiX Development LLC
  • Novartis AG

IN ADDITION, DUE TO VARIOUS FACTORS, INCLUDING INEFFICIENT DRUG DELIVERY TECHNIQUES, DISEASE RELAPSE IS CONSIDERED TO BE A MAJOR CONCERN IN SUCH CANCERS.

  • Drug Development
  • North America
  • United States
  • Market Size
  • Seattle Genetics, Inc.

The company has also designed an emulsiphan nanoemulsion-based drug delivery system to target the drugs directly into cancer cells, thereby increasing efficacy and reducing toxicity of the delivered agents.

  • Drug Development
  • North America
  • Celgene Corporation
  • Novartis AG
  • Polaris Pharmaceuticals, Inc.
  • BIOFLO PICC LINE EXTENSION - PRODUCT DESCRIPTION
  • UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW

The division had strong mid-teens growth in Pain Stimulation on the strength of the recently launched Intellis(TM) platform for spinal cord stimulation, as well as mid-single digit growth in Targeted Drug Delivery and Interventional Pain.

  • Catheter
  • Drug Development
  • North America
  • Company Financials
  • Medtronic, Inc.

SEVERAL ORAL DRUG DELIVERY PLATFORMS HAVE BEEN DEVELOPED BY VARIOUS PLAYERS IN ORDER TO DEVELOP ORAL FORMULATIONS OF GLP-## AGONISTS.

  • Drug Development
  • North America
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • Sanofi S.A.

THE DEVELOPERS ARE SEEKING APPROVAL FOR TWO DELIVERY FORMS IF THE DRUG, A SINGLE DOSE PREFILLED SYRINGE AND AN AUTOINJECTOR DEVICE.

  • Drug Development
  • North America
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Eli Lilly & Co.

Food and Drug Administration.

  • Clinical Trial
  • Drug Development
  • Hospital
  • North America
  • Baxter International Inc.

Catalent Pharma Solutions opened a new business unit, Advanced Delivery Technologies, focusing on innovations in drug delivery technologies along with the optimization of the company' s multiple technologies, global commercial manufacturing network, investments, and R&

  • Drug Development
  • North America
  • Supply
  • Almac Discovery Ltd.
  • Catalent Pharma Solutions, Inc.

FURTHER, NOVEL DRUG DELIVERY METHODS ##. ##. ##.

  • Drug Development
  • North America
  • Amgen Inc.
  • MedImmune, LLC
  • Novartis AG
  • CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2017-2024 (USD MILLION)
  • 7.2 DRUG DISCOVERY

Moreover, the introduction and commercialization of new drug delivery technologies, especially for biologics, and new approaches for disease treatments are expected to greatly expand the applications of ADME in drug discovery and development.

  • Biotech Diagnostics
  • Drug Development
  • North America
  • Forecast
  • Merck & Co., Inc.

For local delivery and ex vivo cell-based therapeutic applications, our compounds do not require delivery vehicles.

  • Drug Development
  • Pharmaceutical
  • North America
  • Product Initiative
  • RXi Pharmaceuticals Corporation

THE WT-## SPECIFIC T-CELL DELIVERY WAS WELL TOLERATED.

  • Drug Development
  • North America
  • Cellectis S.A.
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.
  • SMART-1 DES - PRODUCT DESCRIPTION
  • MIV THERAPEUTICS INC PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW

Bioabsorbable stents help in better drug delivery compared to metallic stents.

  • Clinical Trial
  • Drug Development
  • Medical Device
  • North America
  • REVA Medical, Inc.

THE EFFECT OF THE GLASS VIAL, THE SHIPPING SOLUTION, THE NEEDLE USED TO WITHDRAW THE CELLS INTO THE DELIVERY SYRINGE AND THE MODE OF DELIVERY WERE ALL CAREFULLY OPTIMIZED TO ENSURE MAXIMUM CELL VIABILITY.

  • Drug Development
  • Medical Biotechnology
  • North America
  • Product Initiative
  • RXi Pharmaceuticals Corporation

SynVivo designs and manufactures microfluidic chips that provide a physiologically realistic microfluidic environment which allows the real-time study of cellular behavior and drug delivery.

  • Drug Development
  • North America
  • United States
  • Forecast
  • InSphero AG

WE HAD GOOD GROWTH IN DISPOSABLE PRODUCT SALES THIS QUARTER, INCLUDING STRONG ORDERS FROM OUR DRUG DELIVERY PARTNERS.

  • Diagnostic Imaging
  • Drug Development
  • Magnetic Resonance Imaging
  • North America
  • Company

FURTHERMORE, NOVEL DRUG DELIVERY METHODS ARE BEING EVALUATED TO AIM THE INFECTED CELLS MORE SPECIFICALLY.

  • Drug Development
  • North America
  • Agenus Inc.
  • Incyte Corporation
  • Merck & Co., Inc.
  • PROTEIN ASSAYS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2015-2022 (USD MILLION)

Continuous research for developing alternative and efficient drug delivery methods is also expected to drive the growth of the drug discovery and development application segment.

  • Drug Development
  • North America
  • Forecast
  • Market Size
  • Thermo Fisher Scientific, Inc.

Continuous research for alternative and efficient drug delivery methods will also drive the drug discovery segment, in turn driving the demand for glycomics technologies.

  • Drug Development
  • North America
  • Forecast
  • Market Size
  • Agilent Technologies, Inc.

SUSTAINED RELEASE DRUG DELIVERY DEVICES MARKET ##. ##. ##. ##.

  • Drug Development
  • Eye Disease
  • Ophthalmology
  • North America
  • Glaukos Corporation